Skip to main content
Premium Trial:

Request an Annual Quote

Cheer Up, Pharma Researchers. You Could Be Working in the Auto Industry

If you're in the mood for a downer, Derek Lowe's blog post at In the Pipeline doesn't disappoint. Starting with some musings on GlaxoSmithKline's earnings -- which revealed the "magnitude of their Avandia problem" -- Lowe writes about the layoff epidemic that has plagued the pharma industry this year. He reminds readers of the multi-thousand employee cuts at Pfizer, Bayer-Schering, AstraZeneca, Amgen, and Johnson & Johnson. With Glaxo's news and announcement of impending layoffs there as well as gloom from Novartis, Lowe says we haven't seen the end of the epidemic yet.

 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.